» Articles » PMID: 30349264

Effects of Cognitive Behavioral Therapy for Depression on Improving Insomnia and Quality of Life in Chinese Women with Breast Cancer: Results of a Randomized, Controlled, Multicenter Trial

Abstract

Purpose: Cognitive behavioral therapy (CBT) for depression had been found to be effective in reducing depressive and anxiety symptoms in breast cancer survivors. It is not known whether CBT for depression would also improve insomnia and quality of life (QOL). The aim of this study was to investigate whether CBT for depression would improve insomnia and QOL in a randomized controlled multicenter trial.

Patients And Methods: In this study, breast cancer survivors (n=392) were randomly allocated to the following three groups: CBT (n=98), self-care management (SCM, n=98), and usual care (UC, n=196) in a ratio of 1:1:2. CBT and SCM received a series of nine sessions for 12 weeks, whereas UC received UC only. Insomnia and QOL were evaluated using Athens Insomnia Scale (AIS) and Functional Assessment of Cancer Therapy-Breast (FACT-B) questionnaire at baseline, 4, 12, and 24 weeks.

Results: There was a significant intergroup difference in AIS and FACT-B scores (both <0.01). CBT showed less insomnia problems and better overall QOL compared with those in SCM and UC (both <0.01). No significant differences were found between SCM and UC in insomnia problems and overall QOL. Moreover, the effects of CBT on insomnia and QOL were maintained during the follow-up period.

Conclusion: CBT for depression can be effective in improving insomnia problems and QOL in the Chinese breast cancer survivors.

Citing Articles

The Effectiveness of Cognitive Behavioral Therapy on Depression and Anxiety Symptoms in Breast Cancer Patients and Survivors: A Systematic Review of Interventional Studies.

Azizi M, Heshmatnia F, Milani H, Shahhosseini Z, Marvdashti L, Behboodi Moghadam Z Brain Behav. 2024; 14(10):e70098.

PMID: 39467209 PMC: 11516068. DOI: 10.1002/brb3.70098.


Trajectories of depression and predictors in lung cancer patients undergoing chemotherapy: growth mixture model.

Luo Y, Mao D, Zhang L, Zhu B, Yang Z, Miao J BMC Psychiatry. 2024; 24(1):578.

PMID: 39182063 PMC: 11344456. DOI: 10.1186/s12888-024-06029-y.


A randomized, controlled trial to investigate cognitive behavioral therapy in prevention and treatment of acute oral mucositis in patients with locoregional advanced nasopharyngeal carcinoma undergoing chemoradiotherapy.

He L, Xiao S, Jiang C, Wu X, Liu W, Fan C Front Oncol. 2023; 13:1143401.

PMID: 37350940 PMC: 10282775. DOI: 10.3389/fonc.2023.1143401.


Tackling Insomnia Symptoms through Vestibular Stimulation in Patients with Breast Cancer: A Perspective Paper.

Perrier J, Galin M, Denise P, Giffard B, Quarck G Cancers (Basel). 2023; 15(11).

PMID: 37296867 PMC: 10252132. DOI: 10.3390/cancers15112904.


Psychological interventions for women with non-metastatic breast cancer.

Jassim G, Doherty S, Whitford D, Khashan A Cochrane Database Syst Rev. 2023; 1:CD008729.

PMID: 36628983 PMC: 9832339. DOI: 10.1002/14651858.CD008729.pub3.


References
1.
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U . Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011; 135(1-3):10-9. DOI: 10.1016/j.jad.2011.01.011. View

2.
Harvey A . A cognitive model of insomnia. Behav Res Ther. 2002; 40(8):869-93. DOI: 10.1016/s0005-7967(01)00061-4. View

3.
Gold M, Dunn L, Phoenix B, Paul S, Hamolsky D, Levine J . Co-occurrence of anxiety and depressive symptoms following breast cancer surgery and its impact on quality of life. Eur J Oncol Nurs. 2015; 20:97-105. PMC: 4706814. DOI: 10.1016/j.ejon.2015.06.003. View

4.
Fan L, Strasser-Weippl K, Li J, St Louis J, Finkelstein D, Yu K . Breast cancer in China. Lancet Oncol. 2014; 15(7):e279-89. DOI: 10.1016/S1470-2045(13)70567-9. View

5.
Shinmei I, Kobayashi K, Oe Y, Takagishi Y, Kanie A, Ito M . Cognitive behavioral therapy for depression in Japanese Parkinson's disease patients: a pilot study. Neuropsychiatr Dis Treat. 2016; 12:1319-31. PMC: 4908947. DOI: 10.2147/NDT.S104777. View